Cme Group annual stock-based compensation
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Cme Group Stock-Based Compensation Growth & History (CME)
Cme Group's stock-based compensation was $94.8M for fiscal 2025.
View full Cme Group company overviewCme Group annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $94.8M | $5.3M | +5.92% |
| 2024 | 2024-12-31 | $89.5M | $6.6M | +7.96% |
| 2023 | 2023-12-31 | $82.9M | −$1.4M | −1.66% |
| 2022 | 2022-12-31 | $84.3M | $9.1M | +12.10% |
| 2021 | 2021-12-31 | $75.2M | −$20.8M | −21.67% |
| 2020 | 2020-12-31 | $96.0M | $22.9M | +31.33% |
| 2019 | 2019-12-31 | $73.1M | −$23.4M | −24.25% |
| 2018 | 2018-12-31 | $96.5M | $38.5M | +66.38% |
| 2017 | 2017-12-31 | $58.0M | −$8.2M | −12.39% |
| 2016 | 2016-12-31 | $66.2M | $5.4M | +8.88% |
| 2015 | 2015-12-31 | $60.8M | $6.0M | +10.95% |
| 2014 | 2014-12-31 | $54.8M | $400,000 | +0.74% |
| 2013 | 2013-12-31 | $54.4M | −$7.0M | −11.40% |
| 2012 | 2012-12-31 | $61.4M | $10.1M | +19.69% |
| 2011 | 2011-12-31 | $51.3M | $10.4M | +25.43% |
| 2010 | 2010-12-31 | $40.9M | $7.5M | +22.46% |
| 2009 | 2009-12-31 | $33.4M | −$4.2M | −11.17% |
| 2008 | 2008-12-31 | $37.6M | $14.7M | +64.19% |
| 2007 | 2007-12-31 | $22.9M | — | — |
Cme Group quarterly stock-based compensation
Q3.08
Q1.09
Q2.09
Q3.09
Q4.09
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $24.8M | $4.1M | +19.81% |
| Q1 2026 | 2026-03-31 | $21.8M | $600,000 | +2.83% |
| Q4 2025 | 2025-12-31 | $28.9M | $1.8M | +6.64% |
| Q3 2025 | 2025-09-30 | $24.0M | $3.7M | +18.23% |
| Q2 2025 | 2025-06-30 | $20.7M | $1.9M | +10.11% |
| Q1 2025 | 2025-03-31 | $21.2M | −$2.1M | −9.01% |
| Q4 2024 | 2024-12-31 | $27.1M | $2.8M | +11.52% |
| Q3 2024 | 2024-09-30 | $20.3M | $1.4M | +7.41% |
| Q2 2024 | 2024-06-30 | $18.8M | −$700,000 | −3.59% |
| Q1 2024 | 2024-03-31 | $23.3M | $3.1M | +15.35% |
| Q4 2023 | 2023-12-31 | $24.3M | −$1.2M | −4.71% |
| Q3 2023 | 2023-09-30 | $18.9M | −$500,000 | −2.58% |
| Q2 2023 | 2023-06-30 | $19.5M | $100,000 | +0.52% |
| Q1 2023 | 2023-03-31 | $20.2M | $200,000 | +1.00% |
| Q4 2022 | 2022-12-31 | $25.5M | $6.9M | +37.10% |
| Q3 2022 | 2022-09-30 | $19.4M | $3.8M | +24.36% |
| Q2 2022 | 2022-06-30 | $19.4M | $0 | 0.00% |
| Q1 2022 | 2022-03-31 | $20.0M | −$1.6M | −7.41% |
| Q4 2021 | 2021-12-31 | $18.6M | −$8.1M | −30.34% |
| Q3 2021 | 2021-09-30 | $15.6M | −$8.2M | −34.45% |
| Q2 2021 | 2021-06-30 | $19.4M | −$3.0M | −13.39% |
| Q1 2021 | 2021-03-31 | $21.6M | −$1.5M | −6.49% |
| Q4 2020 | 2020-12-31 | $26.7M | $24.4M | +1060.87% |
| Q3 2020 | 2020-09-30 | $23.8M | $9.4M | +65.28% |
| Q2 2020 | 2020-06-30 | $22.4M | −$15.7M | −41.21% |
| Q1 2020 | 2020-03-31 | $23.1M | $4.8M | +26.23% |
| Q4 2019 | 2019-12-31 | $2.3M | −$43.7M | −95.00% |
| Q3 2019 | 2019-09-30 | $14.4M | −$2.2M | −13.25% |
| Q2 2019 | 2019-06-30 | $38.1M | $21.9M | +135.19% |
| Q1 2019 | 2019-03-31 | $18.3M | $600,000 | +3.39% |
| Q4 2018 | 2018-12-31 | $46.0M | $30.8M | +202.63% |
| Q3 2018 | 2018-09-30 | $16.6M | $1.5M | +9.93% |
| Q2 2018 | 2018-06-30 | $16.2M | $3.4M | +26.56% |
| Q1 2018 | 2018-03-31 | $17.7M | $2.8M | +18.79% |
| Q4 2017 | 2017-12-31 | $15.2M | −$8.7M | −36.40% |
| Q3 2017 | 2017-09-30 | $15.1M | $2.8M | +22.76% |
| Q2 2017 | 2017-06-30 | $12.8M | −$1.2M | −8.57% |
| Q1 2017 | 2017-03-31 | $14.9M | −$1.1M | −6.88% |
| Q4 2016 | 2016-12-31 | $23.9M | $8.3M | +53.21% |
| Q3 2016 | 2016-09-30 | $12.3M | $800,000 | +6.96% |
| Q2 2016 | 2016-06-30 | $14.0M | −$5.0M | −26.32% |
| Q1 2016 | 2016-03-31 | $16.0M | $1.3M | +8.84% |
| Q4 2015 | 2015-12-31 | $15.6M | $1.7M | +12.23% |
| Q3 2015 | 2015-09-30 | $11.5M | −$3.0M | −20.69% |
| Q2 2015 | 2015-06-30 | $19.0M | $5.8M | +43.94% |
| Q1 2015 | 2015-03-31 | $14.7M | $1.5M | +11.36% |
| Q4 2014 | 2014-12-31 | $13.9M | −$100,000 | −0.71% |
| Q3 2014 | 2014-09-30 | $14.5M | $100,000 | +0.69% |
| Q2 2014 | 2014-06-30 | $13.2M | −$400,000 | −2.94% |
| Q1 2014 | 2014-03-31 | $13.2M | $800,000 | +6.45% |
| Q4 2013 | 2013-12-31 | $14.0M | $1.4M | +11.11% |
| Q3 2013 | 2013-09-30 | $14.4M | $600,000 | +4.35% |
| Q2 2013 | 2013-06-30 | $13.6M | −$7.1M | −34.30% |
| Q1 2013 | 2013-03-31 | $12.4M | −$1.9M | −13.29% |
| Q4 2012 | 2012-12-31 | $12.6M | −$1.2M | −8.70% |
| Q3 2012 | 2012-09-30 | $13.8M | $1.0M | +7.81% |
| Q2 2012 | 2012-06-30 | $20.7M | $8.0M | +62.99% |
| Q1 2012 | 2012-03-31 | $14.3M | $2.3M | +19.17% |
| Q4 2011 | 2011-12-31 | $13.8M | $800,000 | +6.15% |
| Q3 2011 | 2011-09-30 | $12.8M | $3.8M | +42.22% |
| Q2 2011 | 2011-06-30 | $12.7M | $3.1M | +32.29% |
| Q1 2011 | 2011-03-31 | $12.0M | $2.7M | +29.03% |
| Q4 2010 | 2010-12-31 | $13.0M | $3.2M | +32.65% |
| Q3 2010 | 2010-09-30 | $9.0M | $2.3M | +34.33% |
| Q2 2010 | 2010-06-30 | $9.6M | $1.3M | +15.66% |
| Q1 2010 | 2010-03-31 | $9.3M | $700,000 | +8.14% |
| Q4 2009 | 2009-12-31 | $9.8M | — | — |
| Q3 2009 | 2009-09-30 | $6.7M | −$6.9M | −50.74% |
| Q2 2009 | 2009-06-30 | $8.3M | — | — |
| Q1 2009 | 2009-03-31 | $8.6M | — | — |
| Q3 2008 | 2008-09-30 | $13.6M | — | — |
Cme Group stock-based compensation trends
Over the last five fiscal years, Cme Group's stock-based compensation decreased from $96.0M to $94.8M, a change of −$1.2M. The latest reported quarter, Q2 2026, shows $24.8M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cme Group source filings ↗Community posts
CME plans European dairy futures and options through EEX transition
CME Group ($CME) agreed with the European Energy Exchange to transition EEX’s European dairy business, including its butter and skimmed-milk-powder indices, as EEX phases out those products. CME plans to establish its own European dairy ind ...
CME sets an FX open-interest record of 4.41 million contracts
CME Group reported a new foreign-exchange derivatives milestone on 7 September 2026. Reported records FX futures and options open interest reached 4,410,167 contracts on 4 September, exceeding the previous 4,269,622 record from 11 June. Tha ...